BE556141A - - Google Patents

Info

Publication number
BE556141A
BE556141A BE556141DA BE556141A BE 556141 A BE556141 A BE 556141A BE 556141D A BE556141D A BE 556141DA BE 556141 A BE556141 A BE 556141A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of BE556141A publication Critical patent/BE556141A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE556141D 1956-03-27 BE556141A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US574102A US2887438A (en) 1956-03-27 1956-03-27 Prolonged action tablets

Publications (1)

Publication Number Publication Date
BE556141A true BE556141A (pt)

Family

ID=24294699

Family Applications (1)

Application Number Title Priority Date Filing Date
BE556141D BE556141A (pt) 1956-03-27

Country Status (5)

Country Link
US (1) US2887438A (pt)
BE (1) BE556141A (pt)
FR (1) FR1249216A (pt)
GB (1) GB837328A (pt)
NL (1) NL108838C (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2053007A1 (en) * 1969-06-24 1971-04-16 Boehringer Mannheim Gmbh Therapeutic prepns with controlled resorp - tion

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB906422A (en) * 1958-05-02 1962-09-19 Wellcome Found Improvements in and relating to prolonged acting pharmaceutical preparations
US3096248A (en) * 1959-04-06 1963-07-02 Rexall Drug & Chemical Company Method of making an encapsulated tablet
US3062720A (en) * 1959-05-20 1962-11-06 Philips Roxane Sustained release pharmaceutical tablet
NL122039C (pt) * 1960-10-20
NL297088A (pt) * 1961-01-31
US3198700A (en) * 1961-05-29 1965-08-03 Blessings Inc Sedative tablet and method for producing the same
DE1228757B (de) * 1962-06-28 1966-11-17 Haessle Ab Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
US3256153A (en) * 1963-02-08 1966-06-14 Smith Kline French Lab Method of stabilizing wax-fat coating materials and product thereof
US3276949A (en) * 1963-05-07 1966-10-04 Olin Mathieson Tablets comprising calcium hypochlorite and sodium sulfate and method of preparation
US3336200A (en) * 1963-05-28 1967-08-15 Warner Lambert Pharmaceutical Tablet structure
US4248856A (en) * 1979-07-10 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4309406A (en) * 1979-07-10 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
SE8404467D0 (sv) * 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations
SE463541B (sv) * 1987-08-31 1990-12-10 Lejus Medical Ab Granulaer produkt oeverdragen av en smaelta av sig sjaelv samt foerfarande foer dess framstaellning
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
US5714167A (en) * 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US5690959A (en) * 1993-05-29 1997-11-25 Smithkline Beecham Corporation Pharmaceutical thermal infusion process
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
WO1996031197A1 (en) * 1995-04-03 1996-10-10 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
US5827537A (en) * 1995-05-04 1998-10-27 Smithkline Beecham Corporation Pharmaceutical thermal infusion process
EA008944B1 (ru) * 2003-10-01 2007-10-26 Люпин Лимитед Фармацевтическая композиция управляемого высвобождения и способ ее получения
EP1523979A1 (en) * 2003-10-13 2005-04-20 Wyeth Extended release pharmaceutical dosage form
ATE474560T1 (de) * 2005-12-14 2010-08-15 Cipla Ltd Pharmazeutische kombination aus nucleotid und nucleosid-reverse-transkriptase-hemmern (wie tenofovir und lamivudin) in verschiedenen teilen der dosiereinheit

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE24090E (en) * 1955-11-15 Impregnated salt tablet
GB514047A (en) * 1938-03-25 1939-10-30 Ernest Edmund Wells Improvements in and relating to processes for manufacturing insulated products in the form of powder
US2413419A (en) * 1943-02-27 1946-12-31 Searle & Co Pellet for administering gonadotropic pituitary hormones
US2757124A (en) * 1952-03-08 1956-07-31 Merck & Co Inc Tablets and method of producing same
US2738303A (en) * 1952-07-18 1956-03-13 Smith Kline French Lab Sympathomimetic preparation
US2793979A (en) * 1953-03-30 1957-05-28 Smith Kline French Lab Method of making a sustained release pharmaceutical tablet and product of the method
US2736682A (en) * 1954-10-11 1956-02-28 Victor M Hermelin Method of making a prolonged action medicinal tablet

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2053007A1 (en) * 1969-06-24 1971-04-16 Boehringer Mannheim Gmbh Therapeutic prepns with controlled resorp - tion

Also Published As

Publication number Publication date
GB837328A (en) 1960-06-09
US2887438A (en) 1959-05-19
NL108838C (pt)
FR1249216A (fr) 1960-12-30

Similar Documents

Publication Publication Date Title
AT202855B (pt)
AT216255B (pt)
AT199361B (pt)
AT202354B (pt)
AT213780B (pt)
AT195843B (pt)
AT194202B (pt)
AT196732B (pt)
AT202279B (pt)
AT201309B (pt)
DE1067222B (pt)
AT198966B (pt)
AT194993B (pt)
AT197107B (pt)
AT195165B (pt)
AT199904B (pt)
AT201021B (pt)
AT199054B (pt)
AT201431B (pt)
AT198988B (pt)
AT211020B (pt)
AT195164B (pt)
AT196945B (pt)
AT196779B (pt)
AT195842B (pt)